These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10954581

  • 1. The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages.
    Alfano M, Pushkarsky T, Poli G, Bukrinsky M.
    J Virol; 2000 Sep; 74(18):8767-70. PubMed ID: 10954581
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.
    Alfano M, Vallanti G, Biswas P, Bovolenta C, Vicenzi E, Mantelli B, Pushkarsky T, Rappuoli R, Lazzarin A, Bukrinsky M, Poli G.
    J Immunol; 2001 Feb 01; 166(3):1863-70. PubMed ID: 11160233
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer.
    Rizzi C, Alfano M, Bugatti A, Camozzi M, Poli G, Rusnati M.
    Eur J Immunol; 2004 Feb 01; 34(2):530-6. PubMed ID: 14768058
    [Abstract] [Full Text] [Related]

  • 5. Pertussis toxin enhances human immunodeficiency virus type 1 replication.
    Momoi Y, Ichiyama K, Chowdhury IH, Koyanagi Y, Yamamoto N.
    AIDS Res Hum Retroviruses; 2000 Mar 01; 16(4):373-9. PubMed ID: 10716375
    [Abstract] [Full Text] [Related]

  • 6. Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1.
    Rizzi C, Crippa MP, Jeeninga RE, Berkhout B, Blasi F, Poli G, Alfano M.
    J Immunol; 2006 Jan 15; 176(2):999-1006. PubMed ID: 16393986
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K, Miyake H, Furuta RA, Fujisawa JI, Iizawa Y, Kanzaki N, Shiraishi M, Okonogi K, Baba M.
    Antimicrob Agents Chemother; 2001 Dec 15; 45(12):3538-43. PubMed ID: 11709336
    [Abstract] [Full Text] [Related]

  • 8. B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity.
    Iordanskiy S, Iordanskaya T, Quivy V, Van Lint C, Bukrinsky M.
    Virology; 2002 Oct 10; 302(1):195-206. PubMed ID: 12429528
    [Abstract] [Full Text] [Related]

  • 9. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ, Zhang C.
    Virology; 1995 Aug 01; 211(1):157-69. PubMed ID: 7645208
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA.
    J Virol; 1997 Sep 01; 71(9):6486-94. PubMed ID: 9261367
    [Abstract] [Full Text] [Related]

  • 12. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes.
    Canki M, Thai JN, Chao W, Ghorpade A, Potash MJ, Volsky DJ.
    J Virol; 2001 Sep 01; 75(17):7925-33. PubMed ID: 11483737
    [Abstract] [Full Text] [Related]

  • 13. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H, He J, Fong S, Wilcox G, Wood C.
    J Virol; 2000 Mar 01; 74(6):2703-13. PubMed ID: 10684286
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue.
    Alfano M, Grivel JC, Ghezzi S, Corti D, Trimarchi M, Poli G, Margolis L.
    AIDS; 2005 Jul 01; 19(10):1007-14. PubMed ID: 15958831
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
    Raymond AD, Hasham M, Tsygankov AY, Henderson EE.
    Virology; 2006 Sep 01; 352(2):253-67. PubMed ID: 16780912
    [Abstract] [Full Text] [Related]

  • 20. Herpesvirus saimiri terminal membrane proteins modulate HIV-1 replication by altering Nef and Tat functions.
    Raymond AD, Hasham M, Tsygankov AY, Henderson EE.
    Curr HIV Res; 2007 Jan 01; 5(1):79-86. PubMed ID: 17266559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.